FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2132891287> ?p ?o ?g. }

• W2132891287 endingPage "742" @default.
• W2132891287 startingPage "739" @default.
• W2132891287 abstract "<b>Aim:</b> To investigate whether the presence of serum antibodies against myelin oligodendrocyte glycoprotein (MOG) and myelin basic protein (MBP) in patients with a clinically isolated syndrome (CIS) predicts the interval to develop more frequently and earlier a first relapse (clinically definite multiple sclerosis: CDMS) than seronegative patients. <b>Methods:</b> Sera from 45 patients with a CIS and positive intrathecal IgG-synthesis were retrospectively tested for the presence of IgM antibodies against both MOG and MBP. Antibodies were detected by immunoblot using recombinant MOG (1–125) and human MBP antigen preparations. Clinical follow ups were performed retrospectively by telephone interviews and documented neurological examination. <b>Results:</b> Using the Cox proportional hazards model there was no significant increased risk for developing CDMS in anti-MOG and anti-MBP positive patients compared with negative. However regarding the median of the time span between CIS and CDMS over the whole follow up, antibody positive patients (MOG/MBP +/+) developed significantly earlier relapses (median 5.5 months (range 3–20)) than the antibody negative ones (median 25.0 months (range 7–43); p<0.006). On testing sera from 56 apparently healthy students, quite high frequencies of anti-MOG and anti-MBP antibodies (21% and 28% respectively) were detected. This limited specificity of anti-MOG and anti-MBP antibodies has been seen earlier and restricts their diagnostic relevance in MS despite their role as a predictor of relapses after a CIS. <b>Conclusions:</b> This study confirms previous data only in a subanalysis indicating that patients with positive anti-MOG/MBP antibodies develop earlier relapses than patients who are antibody negative. However, the authors could not verify that the presence of these antibodies anticipates the overall risk of developing CDMS—according to study criteria—after a first demyelinating event within the study period of 21–106 months (mean 60 (SD 25))." @default.
• W2132891287 created "2016-06-24" @default.
• W2132891287 creator A5001512833 @default.
• W2132891287 creator A5023827392 @default.
• W2132891287 creator A5060641186 @default.
• W2132891287 creator A5060874709 @default.
• W2132891287 date "2006-06-01" @default.
• W2132891287 modified "2023-09-27" @default.
• W2132891287 title "Antimyelin antibodies and the risk of relapse in patients with a primary demyelinating event" @default.
• W2132891287 cites W1963588217 @default.
• W2132891287 cites W1966515383 @default.
• W2132891287 cites W1974821266 @default.
• W2132891287 cites W1975085160 @default.
• W2132891287 cites W1990903507 @default.
• W2132891287 cites W1992742244 @default.
• W2132891287 cites W1997236586 @default.
• W2132891287 cites W1999644537 @default.
• W2132891287 cites W2011595922 @default.
• W2132891287 cites W2016665384 @default.
• W2132891287 cites W2018289835 @default.
• W2132891287 cites W2028435653 @default.
• W2132891287 cites W2047654165 @default.
• W2132891287 cites W2074074558 @default.
• W2132891287 cites W2086080135 @default.
• W2132891287 cites W2101108802 @default.
• W2132891287 cites W2101659599 @default.
• W2132891287 cites W2105490558 @default.
• W2132891287 cites W2125422382 @default.
• W2132891287 cites W2137350492 @default.
• W2132891287 cites W2147062889 @default.
• W2132891287 cites W2155789219 @default.
• W2132891287 cites W4250145052 @default.
• W2132891287 doi "https://doi.org/10.1136/jnnp.2005.077784" @default.
• W2132891287 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2077442" @default.
• W2132891287 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16705196" @default.
• W2132891287 hasPublicationYear "2006" @default.
• W2132891287 type Work @default.
• W2132891287 sameAs 2132891287 @default.
• W2132891287 citedByCount "59" @default.
• W2132891287 countsByYear W21328912872012 @default.
• W2132891287 countsByYear W21328912872013 @default.
• W2132891287 countsByYear W21328912872014 @default.
• W2132891287 countsByYear W21328912872015 @default.
• W2132891287 countsByYear W21328912872016 @default.
• W2132891287 countsByYear W21328912872017 @default.
• W2132891287 countsByYear W21328912872018 @default.
• W2132891287 countsByYear W21328912872019 @default.
• W2132891287 countsByYear W21328912872022 @default.
• W2132891287 countsByYear W21328912872023 @default.
• W2132891287 crossrefType "journal-article" @default.
• W2132891287 hasAuthorship W2132891287A5001512833 @default.
• W2132891287 hasAuthorship W2132891287A5023827392 @default.
• W2132891287 hasAuthorship W2132891287A5060641186 @default.
• W2132891287 hasAuthorship W2132891287A5060874709 @default.
• W2132891287 hasBestOaLocation W21328912872 @default.
• W2132891287 hasConcept C126322002 @default.
• W2132891287 hasConcept C147483822 @default.
• W2132891287 hasConcept C159654299 @default.
• W2132891287 hasConcept C203014093 @default.
• W2132891287 hasConcept C2778486448 @default.
• W2132891287 hasConcept C2779357208 @default.
• W2132891287 hasConcept C2780640218 @default.
• W2132891287 hasConcept C2781028063 @default.
• W2132891287 hasConcept C71924100 @default.
• W2132891287 hasConcept C90924648 @default.
• W2132891287 hasConceptScore W2132891287C126322002 @default.
• W2132891287 hasConceptScore W2132891287C147483822 @default.
• W2132891287 hasConceptScore W2132891287C159654299 @default.
• W2132891287 hasConceptScore W2132891287C203014093 @default.
• W2132891287 hasConceptScore W2132891287C2778486448 @default.
• W2132891287 hasConceptScore W2132891287C2779357208 @default.
• W2132891287 hasConceptScore W2132891287C2780640218 @default.
• W2132891287 hasConceptScore W2132891287C2781028063 @default.
• W2132891287 hasConceptScore W2132891287C71924100 @default.
• W2132891287 hasConceptScore W2132891287C90924648 @default.
• W2132891287 hasIssue "6" @default.
• W2132891287 hasLocation W21328912871 @default.
• W2132891287 hasLocation W21328912872 @default.
• W2132891287 hasLocation W21328912873 @default.
• W2132891287 hasLocation W21328912874 @default.
• W2132891287 hasOpenAccess W2132891287 @default.
• W2132891287 hasPrimaryLocation W21328912871 @default.
• W2132891287 hasRelatedWork W1556241727 @default.
• W2132891287 hasRelatedWork W2011247790 @default.
• W2132891287 hasRelatedWork W2011595922 @default.
• W2132891287 hasRelatedWork W2036924619 @default.
• W2132891287 hasRelatedWork W2040191638 @default.
• W2132891287 hasRelatedWork W2761128834 @default.
• W2132891287 hasRelatedWork W3101274966 @default.
• W2132891287 hasRelatedWork W4200595801 @default.
• W2132891287 hasRelatedWork W4221085749 @default.
• W2132891287 hasRelatedWork W4280538986 @default.
• W2132891287 hasVolume "77" @default.
• W2132891287 isParatext "false" @default.
• W2132891287 isRetracted "false" @default.
• W2132891287 magId "2132891287" @default.
• W2132891287 workType "article" @default.